Skye Bioscience, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Cover
- Cover
Financial Statements
Notes to Financial Statements
Accounting Policies
- Summary of Significant Accounting Policies (Policies)
Notes Tables
Notes Details

Related Party Matters (Details)

v3.21.2

Related Party Matters (Details)		3 Months Ended		4 Months Ended	9 Months Ended
Related Party Matters (Details)	Dec. 19, 2019 USD ($)	Sep. 30, 2021 USD ($)	Sep. 30, 2020 USD ($)	Apr. 30, 2021 agreement	Sep. 30, 2021 USD ($)	Sep. 30, 2020 USD ($)	Dec. 31, 2020 USD ($)
Related Party Transaction [Line Items]
Research and development expense		$ 327,731	$ 346,217		$ 1,818,059	$ 1,574,357
Dr. Avtar Dhillon \| Independent Contractor Services Agreement
Related Party Transaction [Line Items]
Monthly fee	$ 10,000
Fees incurred under agreement		30,000	$ 31,000		90,000	$ 97,387
Accrued expense under agreement		20,000			20,000		$ 7,032
Emerald Health Pharmaceuticals \| Month To Month Lease Agreement
Related Party Transaction [Line Items]
Sublease rent					4,000
Costs and expenses, related party		8,830			15,453
Emerald Health Biotechnology Espana, S.L.U. \| Collaborative Research Agreement
Related Party Transaction [Line Items]
Number of collaborative research agreements \| agreement				2
Initial term of research agreement (years)				1 year
Termination terms, period following uncured breach (days)				45 days
Research and development expense		62,940			206,218
Related party prepaid asset		$ 18,125			$ 18,125
Emerald Health Biotechnology Espana, S.L.U. \| Emerald Health Research, Inc \| Collaborative Research Agreement
Related Party Transaction [Line Items]
Ownership percentage (percent)				100.00%

- Definition

Collaborative Arrangement, Rights and Obligations, Initial Term Of Agreement

+ References

No definition available.

+ Details

Name:	skye_CollaborativeArrangementRightsAndObligationsInitialTermOfAgreement
Namespace Prefix:	skye_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Collaborative Arrangement, Rights and Obligations, Number Of Collaborative Research Agreements

+ References

No definition available.

+ Details

Name:	skye_CollaborativeArrangementRightsAndObligationsNumberOfCollaborativeResearchAgreements
Namespace Prefix:	skye_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Collaborative Arrangement, Rights and Obligations, Termination Terms, Period Following Uncured Breach

+ References

No definition available.

+ Details

Name:	skye_CollaborativeArrangementRightsAndObligationsTerminationTermsPeriodFollowingUncuredBreach
Namespace Prefix:	skye_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Prepaid Asset, Related Party

+ References

No definition available.

+ Details

Name:	skye_PrepaidAssetRelatedParty
Namespace Prefix:	skye_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Related Party, Accrued Expense Under Agreement

+ References

No definition available.

+ Details

Name:	skye_RelatedPartyAccruedExpenseUnderAgreement
Namespace Prefix:	skye_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Related Party, Fees Incurred Under Agreement In The Period

+ References

No definition available.

+ Details

Name:	skye_RelatedPartyFeesIncurredUnderAgreementInThePeriod
Namespace Prefix:	skye_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Related Party, Monthly Fee

+ References

No definition available.

+ Details

Name:	skye_RelatedPartyMonthlyFee
Namespace Prefix:	skye_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Related Party, Monthly, Sublease Base Rentals Payment

+ References

No definition available.

+ Details

Name:	skye_RelatedPartyMonthlySubleaseBaseRentalsPayment
Namespace Prefix:	skye_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Costs of sales and operating expenses for the period incurred from transactions with related parties.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.2)
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

+ Details

Name:	us-gaap_CostsAndExpensesRelatedParty
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_RelatedPartyTransactionLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 985
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 730
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373

+ Details

Name:	us-gaap_ResearchAndDevelopmentExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The number of units or percentage investment held in the subsidiary by the limited liability company or limited partnership.

+ References

No definition available.

+ Details

Name:	us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=skye_AvtarDhillonMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionAxis=skye_IndependentContractorServicesAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=skye_EmeraldHealthPharmaceuticalsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionAxis=skye_MonthToMonthLeaseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=skye_EmeraldHealthBiotechnologyEspanaSLUMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionAxis=skye_CollaborativeResearchAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_OwnershipAxis=skye_EmeraldHealthResearchIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: